Ziprasidone hydrochloride
Showing 1 - 25 of 1,883
Acute Mania, Bipolar Disorder, Manic Trial in Worldwide (ziprasidone HCl, olanzapine)
Terminated
- Acute Mania
- Bipolar Disorder, Manic
- ziprasidone hydrochloride
- olanzapine
-
Aachen, Germany
- +18 more
Mar 2, 2021
Treatment-resistant Schizophrenia Trial in Columbus (Clozapine, Antipsychotics,Other (non-Clozapine))
Not yet recruiting
- Treatment-resistant Schizophrenia
- Clozapine
- Antipsychotics,Other (non-Clozapine)
-
Columbus, OhioOhio State University Harding Hospital
Feb 22, 2023
Bipolar Disorder Trial in Canada (Ziprasidone HCL (oral))
Terminated
- Bipolar Disorder
- Ziprasidone HCL (oral)
-
Calgary, Alberta, Canada
- +9 more
Mar 2, 2021
Schizophrenia and Disorders With Psychotic Features Trial in Canada (Ziprasidone HCL (oral))
Terminated
- Schizophrenia and Disorders With Psychotic Features
- Ziprasidone HCL (oral)
-
Calgary, Alberta, Canada
- +31 more
Mar 2, 2021
Bipolar Disorder Therapies
Completed
- Bipolar Disorder
- Lithium Carbonate
- +29 more
-
Albuquerque, New MexicoChristophe G Lambert
Sep 29, 2021
Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)
Recruiting
- Diabetic Peripheral Neuropathic Pain
- HSK16149 20mg BID
-
Luoyang, Henan, ChinaThe First Affiliated Hospital of Henan University of Science and
Nov 2, 2023
Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)
Not yet recruiting
- Laparoscopy
- Anesthesia, Intravenous
-
Guangzhou, Guangdong, China
- +11 more
Oct 15, 2023
Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)
Not yet recruiting
- Breast Cancer
- Mitoxantrone hydrochloride liposome
- Capecitabine
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023
Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)
Active, not recruiting
- Adult Solid Neoplasm
- Erlotinib Hydrochloride
- Irinotecan Hydrochloride
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin
Not yet recruiting
- Pain
- Insomnia
- Compound ibuprofen polyrelease tablets
- reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Feb 6, 2023
Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Propranolol
- Propranolol hydrochloride
- +2 more
- (no location specified)
Jul 31, 2023
Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)
Not yet recruiting
- Platinum-resistant Ovarian Cancer
- Oral Topotecan Combined With Anlotinib
-
Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023
Associated With Cardiomyopathy and Heart Failure After Cancer
Recruiting
- Hodgkin Lymphoma in Remission
- +6 more
- Assessment of Therapy Complications
- +3 more
-
Birmingham, Alabama
- +78 more
Jan 11, 2023
Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)
Not yet recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablets
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 9, 2023
Nausea and Vomiting Trial in Xi'an (Palonosetron HCl capsules)
Recruiting
- Nausea and Vomiting
- Palonosetron hydrochloride capsules
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital, the Air Force Medical University
Jan 18, 2023
Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in
Active, not recruiting
- Pancreatic Acinar Cell Carcinoma
- +8 more
- 3-Dimensional Conformal Radiation Therapy
- +8 more
-
Mobile, Alabama
- +697 more
Nov 16, 2022
Oxycodone Sustained-release Tablets for Moderate to Severe
Recruiting
- Cancer Pain
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Jul 24, 2023
Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in United States (Fluorouracil, Gemcitabine Hydrochloride,
Completed
- Pancreatic Adenocarcinoma
- Resectable Pancreatic Carcinoma
- Fluorouracil
- +5 more
-
Birmingham, Alabama
- +806 more
Oct 18, 2022
Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)
Recruiting
- Lymphoma, Solid Tumors
- Mitoxantrone Hydrochloride Liposome
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 14, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)
Completed
- Male Breast Cancer
- +7 more
- propranolol hydrochloride
- Correlative Studies
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 4, 2022
Knee Osteoarthritis Trial in United Kingdom (Liposomal bupivacaine, Bupivacaine HCl)
Completed
- Knee Osteoarthritis
- Liposomal bupivacaine
- Bupivacaine hydrochloride
-
Birmingham, United Kingdom
- +10 more
Nov 3, 2022
Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Relapsing Multiple Sclerosis
- Mitoxantrone Hydrochloride Liposome Injection
-
Beijing, Beijing, ChinaXuanwu Hospital Capital Medical University
Aug 9, 2022